Article

Recent trends in the management of advanced prostate cancer

2018-09-21

Abstract excerpt

Advanced prostate cancer includes a wide spectrum of disease ranging from hormone naïve or hormone sensitive to castration resistant, both containing populations of men who have demonstrable metastatic and non-metastatic states. The mainstay of treatment for metastatic hormone-sensitive prostate cancer is androgen deprivation therapy (ADT). However, recent level 1 evidence demonstrates that the addition of chemoth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 17ff8e9e-7aa1-5323-b0c8-e27a0f6681c7
DOI: 10.12688/f1000research.15382.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Recent trends in the management of advanced prostate cancerDOI 10.12688/f1000research.15382.1Read

[Metastatic castration-resistant prostate cancer-emerging trends in therapy].Semantic proximity Read

Contemporary Management of Prostate CancerSemantic proximity Read

Novel Target Opportunities in Non-Metastatic Castrate Resistant Prostate CancerSemantic proximity Read

Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysisSemantic proximity Read

Metastatic Prostate Cancer.Semantic proximity Read

Treatment approaches for metastatic cancer of the prostate based on recent molecular evidence.Semantic proximity Read

Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospectsSemantic proximity Read

Androgen deprivation therapy for prostate cancer: current status and future prospects.Semantic proximity Read

Overcoming castration resistance in prostate cancer.Semantic proximity Read

Towards precision oncology in advanced prostate cancerSemantic proximity Read

A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate.Semantic proximity Read

Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysisSemantic proximity Read